Further, the systemic immunosuppression of anti-TNFα therapies hampers the immunogenicity of these vaccines, and in addition, live vaccine (i.e., herpes zoster) was contraindicated in anti-TNFα-treated patients, as it may cause infection from the vaccine virus strain. This evidence concerns the gene TNF and herpes zoster.